Liesha Marie Miller LPCC

Recommended Articles

• Flakka: A Gravel Guised Fatal Drug

  Flakka, an addictive drug that looks similarly to gravel is considered to be closely related with the synthetic cathinone. The drug is known to cause long-lasting damage to the brain cells and can alter the brain's chemistry in such a way that users can lose touch with reality. Having manufactured...

• Are There Effective Treatments For Genital Herpes?

  While there is no cure for genital herpes, there are several treatments that may be effective in providing relief for symptoms. Treatment is not only aimed at relieving symptoms but also helps to reduce the frequency of outbreaks. Certain treatments may even reduce the chances of transmitting...

• The Impact Marijuana Can Have on Type 2 Diabetes Patients

  Now more than ever, citizens across the nation and the world have begun to ponder the potential benefits of marijuana.  As the drug has been classified as a schedule 1 within the United States, research surrounding any potential benefits had been slowed.  With a growing interest in the proposed...

• Does My Diet Raise My Risk for Appendicitis?

  Many people pay little to no attention to the appendix. In fact, the appendix is probably the least studied organ in the body. The case can be confirmed by the fact that even in today’s highly advanced doctors and scientists, they still do not know the exact role of the appendix.The Role and...

• New Herbal Patch May Help to Heal Canker Sores Faster

  According to a new study presented at the 85th general session of the International Association for Dental Research, a novel over-the-counter patch containing licorice extract may help in the quick healing of canker sores. In this study 46 participants who had recurrent canker sores were recruited....

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...